CAMP
CAMP4 THERAPEUTICS CORPORATION
3.80$
+3.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 11,248.6% | 1.1% | – | – | – | – | – | – | 52.3% | 106.9% | 40.2% | – | – | |
| 100.0% | -1.1% | – | – | – | 100.0% | 100.0% | 100.0% | 47.7% | 100.0% | 59.8% | 100.0% | 77.8% | |
| 2,805.4% | 18.8% | – | – | – | 1,533.1% | 1,182.5% | 690.9% | 1,176.9% | 2,401.4% | 745.0% | 608.0% | 905.4% | |
| 819.7% | 5.2% | – | – | – | 719.3% | 444.3% | 279.4% | 578.1% | 1,369.8% | 325.0% | 244.1% | 424.8% | |
| 3,625.1% | 24.0% | – | – | – | 2,252.5% | 1,626.8% | 970.3% | 1,702.6% | 3,771.3% | 1,069.9% | 852.1% | 1,320.3% | |
| -3,525.1% | -25.1% | – | – | – | -2,152.5% | -1,526.8% | -870.3% | -1,655.0% | -3,671.3% | -1,010.1% | -752.1% | -1,242.5% | |
| 449.7% | 2.6% | – | – | – | – | – | – | – | – | – | – | – | |
| -3,341.7% | -24.2% | – | – | – | -2,036.7% | -1,449.1% | -840.8% | -1,899.2% | -11,575.9% | -1,416.6% | -1,884.8% | -2,543.7% | |
| 124.3% | 0.1% | – | – | – | -80.5% | – | – | – | – | – | – | – | |
| -3,341.7% | -24.2% | – | – | – | -2,036.7% | -1,449.1% | -840.8% | -1,899.2% | -11,575.9% | -1,416.6% | -1,884.8% | -2,543.7% | |
| -3,402.3% | -24.0% | – | – | – | -2,088.3% | -1,477.7% | -841.5% | -1,846.9% | -3,564.4% | -969.9% | -1,884.8% | -1,735.5% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.